Phase 2 Depressive Disorder, Major Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
DepressionDepressive DisorderMolecular Mechanisms of Pharmacological Action+10 more
National Institute of Mental Health (NIMH)50 enrolled1 locationNCT06511908
Recruiting
Phase 2
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder
Depressive Disorder, Major
Janssen Research & Development, LLC124 enrolled44 locationsNCT06785012
Recruiting
Phase 2
Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation
Anxiety DisorderDepressive Disorder, Major
Mclean Hospital112 enrolled1 locationNCT05232032
Recruiting
Phase 2
Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
InflammationDepressive Disorder, Major
Massachusetts General Hospital100 enrolled1 locationNCT06136546